Literature DB >> 12414898

VHL2C phenotype in a German von Hippel-Lindau family with concurrent VHL germline mutations P81S and L188V.

Gregor Weirich1, Bettina Klein, Thorsten Wöhl, Dieter Engelhardt, Hiltrud Brauch.   

Abstract

Von Hippel-Lindau disease (VHL) is a multitumor syndrome that develops on the basis of germline mutations in the VHL tumor suppressor gene. Genotype-phenotype correlations have helped to stratify the disease into VHL type 1 (without pheochromocytoma) and VHL type 2A, 2B, and 2C (with pheochromocytoma). VHL2C is characterized by a pheochromocytoma-only phenotype. We report on the P81S germline mutation in a German VHL2C family with the previously identified L188V mutation. The concurrent P81S mutation was identified by novel screening approaches including denaturing HPLC and sequencing. We show the co-segregation of these two mutations with the disease and discuss their possible impact on pVHL function and phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414898     DOI: 10.1210/jc.2002-020651

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  New insights into von Hippel-Lindau function highlighted by investigation of the trichloroethylene-induced p.P81S hotspot mutation.

Authors:  Len Neckers; Christopher J Ricketts; W Marston Linehan
Journal:  J Natl Cancer Inst       Date:  2013-08-29       Impact factor: 13.506

2.  Neuro-ophthalmology of von Hippel-Lindau.

Authors:  Eric W Fitz; Steven A Newman
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

3.  Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease.

Authors:  M Pulcrano; L Camera; L Pagano; S Del Vecchio; D Ferone; L Bodei; A Murgia; L Pace; G Storto; G Paganelli; A Colao; M Salvatore; G Lombardi; B Biondi
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

4.  VHL mutations linked to type 2C von Hippel-Lindau disease cause extensive structural perturbations in pVHL.

Authors:  Katja Knauth; Edward Cartwright; Stefan Freund; Mark Bycroft; Alexander Buchberger
Journal:  J Biol Chem       Date:  2009-02-19       Impact factor: 5.157

Review 5.  Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches.

Authors:  Marcia Helena Soares Costa; Tania M Ortiga-Carvalho; Alice Dutra Violante; Mario Vaisman
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-17       Impact factor: 5.555

Review 6.  Management of Gene Variants of Unknown Significance: Analysis Method and Risk Assessment of the VHL Mutation p.P81S (c.241C>T).

Authors:  Daniela Alosi; Marie Luise Bisgaard; Sophie Nowak Hemmingsen; Lotte Nylandsted Krogh; Hanne Birte Mikkelsen; Marie Louise Mølgaard Binderup
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

7.  Novel genotype-phenotype correlations in five Chinese families with Von Hippel-Lindau disease.

Authors:  Qiuli Liu; Gang Yuan; Dali Tong; Gaolei Liu; Yuting Yi; Jun Zhang; Yao Zhang; Lin-Ang Wang; Luofu Wang; Dianzheng Zhang; Rongrong Chen; Yanfang Guan; Xin Yi; Weihua Lan; Jun Jiang
Journal:  Endocr Connect       Date:  2018-06-05       Impact factor: 3.335

Review 8.  The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.

Authors:  Song Peng; Jun Zhang; Xintao Tan; Yiqiang Huang; Jing Xu; Natalie Silk; Dianzheng Zhang; Qiuli Liu; Jun Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-24       Impact factor: 5.555

Review 9.  Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack.

Authors:  João Castro-Teles; Bernardo Sousa-Pinto; Sandra Rebelo; Duarte Pignatelli
Journal:  Endocr Connect       Date:  2021-10-27       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.